Template:SubstanceBox/Memantine

From Drugwiki

Revision as of 15:35, 29 November 2023 by en>Sulfato (Many users reporting memantine onset time being much shorter than those depicted in this page, some of them feeling a very subtle dissociation 30 minutes after ingestion.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
{{#arraydefine: InhaledDosage | Threshold;, Light;, Common;, Strong;, Heavy; }} {{#arraydefine: InhaledDuration | Total;, Onset;, Come up;, Peak;, Offset;, After effects; }} {{#arraydefine: SmokedDosage | Threshold;< x mg, Light;x - x mg, Common;x - x mg, Strong;x - x mg, Heavy;> x mg }} {{#arraydefine: SmokedDuration | Total;x minutes, Onset;x seconds, Come up;, Peak;x minutes, Offset;x hours, After effects;x hours }} {{#arraydefine: OralDosage | Threshold;Oral threshold dose::10Oral dose units::mg, Light;Oral min light dose::30 - Oral max light dose::70 mg, Common;Oral min common dose::70 - Oral max common dose::110 mg, Strong;Oral min strong dose::110 - Oral max strong dose::170 mg, Heavy;Oral heavy dose::170 mg + }} {{#arraydefine: OralDuration | Total;~ Oral min total time::18 - Oral max total time::36Oral total time units::hours, Onset;Oral min onset time::30 - Oral max onset time::180Oral onset time units::minutes, Come up;Oral min comeup time::2 - Oral max comeup time::3Oral comeup time units::hours, Peak;Oral min peak time::3 - Oral max peak time::12Oral peak time units::hours, Offset;Oral min offset time::5 - Oral max offset time::24Oral offset time units::hours, After effects;Oral min afterglow time::8 - Oral max afterglow time::24Oral afterglow time units::hours }} {{#arraydefine: SublingualDosage | Threshold;, Light;, Common;, Strong;, Heavy; }} {{#arraydefine: SublingualDuration | Total;, Onset;, Come up;, Peak;, Offset;, After effects; }} {{#arraydefine: BuccalDosage | Threshold;, Light;, Common;, Strong;, Heavy; }} {{#arraydefine: BuccalDuration | Total;, Onset;, Come up;, Peak;, Offset;, After effects; }} {{#arraydefine: InsufflatedDosage | Threshold;, Light;, Common;, Strong;, Heavy; }} {{#arraydefine: InsufflatedDuration | Total;, Onset;, Come up;, Peak;, Offset;, After effects; }} {{#arraydefine: RectalDosage | Threshold;, Light;, Common;, Strong;, Heavy; }} {{#arraydefine: RectalDuration | Total;, Onset;, Come up;, Peak;, Offset;, After effects; }} {{#arraydefine: TransdermalDosage | Threshold;, Light;, Common;, Strong;, Heavy; }} {{#arraydefine: TransdermalDuration | Total;, Onset;, Come up;, Peak;, Offset;, After effects; }} {{#arraydefine: SubcutaneousDosage | Threshold;, Light;, Common;, Strong;, Heavy; }} {{#arraydefine: SubcutaneousDuration | Total;, Onset;, Come up;, Peak;, Offset;, After effects; }} {{#arraydefine: IntramuscularDosage | Threshold;, Light;, Common;, Strong;, Heavy; }} {{#arraydefine: IntramuscularDuration | Total;, Onset;, Come up;, Peak;, Offset;, After effects; }} {{#arraydefine: IntravenousDosage | Threshold;, Light;, Common;, Strong;, Heavy; }} {{#arraydefine: IntravenousDuration | Total;, Onset;, Come up;, Peak;, Offset;, After effects; }} {{#arraydefine: uncertaininteractions | {{#ask:SubstanceBox/Memantine |?UncertainInteraction |headers=hide |format=list |mainlabel=- |link=none }} }} {{#arraydefine: unsafeinteractions | {{#ask:SubstanceBox/Memantine |?UnsafeInteraction |headers=hide |format=list |mainlabel=- |link=none }} }} {{#arraydefine: dangerousinteractions | {{#ask:SubstanceBox/Memantine |?DangerousInteraction |headers=hide |format=list |mainlabel=- |link=none }} }} {{#arrayprint:uncertaininteractions||@@@@| }} {{#arrayprint:unsafeinteractions||@@@@| }} {{#arrayprint:dangerousinteractions||@@@@| }}
SubstanceBox/Memantine
Chemical Nomenclature
Common names common name::Memantine, common name::Memaxa, common name::Ebixa, common name::Namenda, common name::Namenda XR, common name::Namzaric (with donepezil, common name::both extended-release)
Substitutive name Memantine
Systematic name 3,5-Dimethyladamantan-1-amine
Class Membership
Psychoactive class psychoactive class::Dissociative
Chemical class chemical class::Adamantane
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



{{#arrayunique: OralDosage}} {{#loop: i | 0 | {{#arraysize: OralDosage}} | {{#arraydefine: val | {{#arrayindex: OralDosage | {{#var: i}} }} | ; }} }} {{#arrayunique: OralDuration}} {{#loop: i | 0 | {{#arraysize: OralDuration}} | {{#arraydefine: val | {{#arrayindex: OralDuration | {{#var: i}} }} | ; }} }}
⇣ Oral
Dosage
Bioavailability 41 - 63%[1]
[[Dosage_classification#{{#arrayindex: val | 0 }}|{{#arrayindex: val | 0 }}]] {{#arrayindex: val | 1 }}
Duration
[[Duration#{{#arrayindex: val | 0 }}|{{#arrayindex: val | 0 }}]] {{#arrayindex: val | 1 }}









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

Interactions
@@@@
@@@@
@@@@
  1. ↑ Lee, S.-H., Kim, S.-H., Noh, Y.-H., Choi, B.-M., Noh, G.-J., Park, W.-D., Kim, E.-J., Cho, I.-H., Bae, C.-S. (February 2016). "Pharmacokinetics of Memantine after a Single and Multiple Dose of Oral and Patch Administration in Rats". Basic & Clinical Pharmacology & Toxicology. 118 (2): 122–127. doi:10.1111/bcpt.12479. ISSN 1742-7843.